http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2469883-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bba842fc4d37dfcaced1b55bc0c91c7c
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
filingDate 2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b067f402e4c0c4939e67e09876ab19f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d14bdfacaf325f6a43ab50f8f82da8ab
publicationDate 2010-11-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-2469883-A
titleOfInvention Novel crystalline form of Prasugrel hydrogensulphate
abstract Crystalline form III of Prasugrel hydrogensulphate. A process for the preparation of this new crystal form, pharmaceutical compositions comprising the same and use of the new crystal form as a pharmaceutical, in particular as a blood platelet aggregation inhibitor. Seed crystals which can be employed in the above mentioned process as well as a process for their preparation are also disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102977116-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102977116-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8603537-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2883877-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8569325-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013150322-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011127300-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8404703-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8193358-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8802854-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9012641-B2
priorityDate 2009-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2003136-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009130289-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009129983-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009098142-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010070677-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID396275
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454204674
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534242
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281963
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1118
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449869614
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60606
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918456
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10158453
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100303708
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25265
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID18441
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID61778
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419583499
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86646623
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412584819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480215

Total number of triples: 50.